The healthcare sector faces resource scarcity, leading decision-makers and providers to operate under constraints. Distortionary practices like corruption and lobbying divert limited resources, impacting patients' welfare. Corruption's far-reaching consequences affect provider-patient relationships and overall trust in the healthcare system. While often studied in low- and middle-income settings, similar distortionary effects occur in high-income settings due to financial ties between stakeholders, including pharmaceutical companies and other stakeholders, such as insurance companies, physicians, nurses, patient and professional associations. The workshop provides a forum of three days for bringing together early-career researchers in economics, political science, public health, health policy, law, sociology, and related fields. Participants will have an opportunity to present their work and receive feedback in a constructive and informal setting.
We invite submissions on topics related to:
- Corruption in health care (petty and grand)
- State and regulatory capture
- International aid and corruption in health
- Measuring and conceptualizing corruption
- Conflicts of interest between pharmaceutical companies and other relevant stakeholders
- Lobbying and industry marketing practices
- Transparency, accountability and anti-corruption